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1998.—A pivotal role for adenosine in the regulation of
coronary blood flow is still controversial. Consequently, we
investigated its role in the regulation of coronary vasomotor
tone in swine at rest and during graded treadmill exercise.
During exercise, myocardial O2 consumption increased from
167 6 18 µmol/min at rest to 399 6 27 µmol/min at 5 km/h
(P # 0.05), which was paralleled by an increase in O2 delivery,
so that myocardial O2 extraction (76 6 1 and 78 6 1% at rest
and 5 km/h, respectively) and coronary venous PO2 (24.5 6 1.0
and 22.8 6 0.3 mmHg at rest and 5 km/h, respectively)
remained unchanged. After adenosine receptor blockade with
8-phenyltheophylline (5 mg/kg iv), the relation between myo-
cardial O2 consumption and coronary vascular resistance was
shifted toward higher resistance, whereas myocardial O2
extraction rose to 81 6 1 and 83 6 1% at rest and 5 km/h and
coronary venous PO2 fell to 19.2 6 0.8 and 18.9 6 0.8 mmHg at
rest and 5 km/h, respectively (all P # 0.05). Thus, although
adenosine is not mandatory for the exercise-induced coronary
vasodilation, it exerts a vasodilator influence on the coronary
resistance vessels in swine at rest and during exercise.
coronary circulation; myocardial oxygen extraction; myocar-
dial oxygen consumption; pulmonary circulation; systemic
circulation
THE NORMAL HEART IS characterized by a high myocar-
dial O2 extraction (ME˙O2), requiring a tight coupling of
coronary blood flow to changing metabolic needs (16,
26). The close coupling of coronary blood flow and
myocardial O2 demand has been proposed to depend
primarily on messengers released from the myocar-
dium, such as adenosine (4, 30). Although adenosine
has been shown to contribute to coronary vasodilation
in isolated rodent hearts, a pivotal role for adenosine in
the regulation of coronary blood flow in the large
mammalian in situ heart is still controversial. Thus
neither increased adenosine catabolism with adenosine
deaminase nor adenosine receptor blockade with the
adenosine A1/A2-receptor blocker 8-phenyltheophylline
(8-PT) altered resting coronary blood flow in anesthe-
tized or awake dogs (2, 22, 24, 33). In addition, during
treadmill exercise, coronary blood flow and resistance,
as well as myocardial O2 consumption (MV˙O2) and
ME˙O2, were not altered by adenosine receptor blockade
or adenosine deaminase (2), suggesting that adenosine
is not mandatory for the regulation of coronary blood
flow in the dog heart at rest or during exercise. In
contrast, several studies have reported that adeno-
sine receptor blockade produced by theophylline in-
creased coronary vascular resistance and ME˙O2 and
decreased coronary blood flow and coronary venous
PO2 (PcvO2) in the human heart under basal conditions
(11–13), whereas only one study reported no change
in resting coronary blood flow after adenosine receptor
blockade with aminophylline (32). Also, in closed-chest
sedated swine, adenosine deaminase produced a small
increase in coronary vasomotor tone under basal condi-
tions (17) while markedly blunting the early coronary
blood flow response to intracoronary infusions of isopro-
terenol (18). Recently, we observed in swine that exer-
cise produced increases in MV˙O2 that were matched by
equivalent increments in coronary blood flow so that
ME˙O2 and PcvO2 were maintained (9). Because inter-
stitial adenosine levels have been reported to increase
during b-adrenergic stimulation with dobutamine in
anesthetized swine at a time when PcvO2 or interstitial
lactate levels did not change (21), it is possible that
adenosine could contribute to the maintained PcvO2 in
swine during exercise. Consequently, in the present
study we investigated the role of adenosine in the
coupling between myocardial O2 delivery (MD˙O2) and
MV˙O2 in awake swine at rest and during graded
treadmill exercise up to 85–90% of maximum heart
rate (4a).
MATERIALS AND METHODS
Crossbred Landrace 3 Yorkshire pigs were used in the
present study. All experiments were performed in accordance
with the ‘‘Guiding Principles in the Care and Use of Labora-
tory Animals,’’ as approved by the Council of the American
Physiological Society and with prior approval of the Animal
Care Committee of the Erasmus University Rotterdam. Adap-
tation of animals to the laboratory conditions started 1 wk
before the day of surgery and continued until 10 days
postoperative. Full details of the experimental procedures
have been published previously (7, 9, 37, 38).
Surgical Procedures
After an overnight fast, seven pigs (23 6 1 kg; 3 males and
4 females) were sedated with ketamine (30 mg/kg im; Ketalin,
Apharmo, Arnhem, The Netherlands), anesthetized with
thiopental sodium (10 mg/kg iv; Rhoˆne-Poulenc, Amstelveen,
The Netherlands), intubated, and mechanically ventilated
with a mixture of O2 and nitrous oxide (1:2) to which 0.2–1.0%
(vol/vol) isoflurane (Forene, Abbott, Amstelveen, The Nether-
lands) was added. Anesthesia was further maintained with
midazolam (2 mg/kg 1 1 mg·kg21 ·h21 iv; Dormicum, Roche,
Mijdrecht, The Netherlands) and fentanyl (10 µg·kg21 ·h21 iv;
Janssen-Cilag, Tilburg, The Netherlands). Under sterile con-
ditions, the chest was opened via the fourth left intercostal
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space, and an 8-Fr fluid-filled polyvinylchloride (PVC) cath-
eter was inserted into the aortic arch for the measurement of
central aortic blood pressure and collection of arterial blood
samples and secured with a purse-string suture. After the
pericardium was opened, an electromagnetic flow probe (14–
15 mm ID) was positioned around the ascending aorta for the
measurement of ascending aortic blood flow (Transflow 601
Systems, Skalar, Delft, The Netherlands). A high-fidelity
pressure transducer (model P4.5, Konigsberg Instruments,
Pasadena, CA) was inserted into the left ventricle (LV) via the
apical dimple for recording of LV pressure and its first
derivative (LV dP/dt; obtained via electrical differentiation).
An 8-Fr PVC catheter was also inserted into the LV for
calibration of the Konigsberg transducer signal; two 8-Fr
PVC catheters were inserted into the pulmonary artery for
measurement of pulmonary arterial pressure, withdrawal of
mixed venous blood samples, and administration of drugs.
Another 8-Fr catheter was inserted into the left atrium for
measurement of left atrial pressure. For the measurement of
coronary blood flow, a Doppler flow probe (2.0, 2.5, or 3.0 mm
ID, emitting frequency 5 20 MHz) was placed around the
proximal part of the left anterior descending (LAD) coronary
artery (model HVPD-20, Crystal Biotech, Northboro, MA)
(23). A small angiocatheter (0.8 mm ID, 1.1 mm OD) con-
nected to a larger Tygon catheter (0.8 mm ID, 2.4 mm OD)
was inserted directly into the anterior interventricular vein
to allow sampling of coronary venous blood (5). Electrical
wires and catheters were tunneled subcutaneously to the
back, the chest was closed, and the animals were allowed to
recover. All electrical wires and catheters were protected with
a vest.
Postsurgical period. After surgery the animals received
analgesia by daily intramuscular injections of 0.3 mg of
buprenorphine (Temgesic, Schering-Plough, Amstelveen, The
Netherlands) during the first 48 h and intravenous injections
of 25 mg/kg of amoxicillin (Clamoxil, Beecham Farma, Am-
stelveen, The Netherlands) and 5 mg/kg gentamicin (A.U.V.,
Cuijk, The Netherlands) on a daily basis during the 1st wk to
prevent infections. Catheters were flushed daily with physi-
ological saline containing 2,000 IU/ml heparin (Leo Pharma-
ceutical Products, Weesp, The Netherlands).
Experimental Protocols
Exercise protocols. Studies were performed 10–20 days
after surgery with animals exercising on a motor-driven
treadmill. Two experimental protocols were performed on
different days and in random order. The first protocol was
performed to establish that two consecutive exercise tests
performed at 90-min intervals produced reproducible results;
in the second protocol the effect of nonselective adenosine
A1/A2-receptor blockade was studied.
Reproducibility of responses to exercise. With swine lying
quietly on the treadmill, resting hemodynamic measure-
ments, consisting of ascending aortic blood flow, LV pressure
and LV dP/dt, blood pressures in the aorta, pulmonary artery,
and left atrium, and the coronary Doppler shift, were ob-
tained, and arterial, mixed venous, and coronary venous
blood samples were collected (9, 38). Aortic, pulmonary, and
left atrial pressures were measured using Combitrans pres-
sure transducers (Braun, Melsungen, Germany) with the
reference point at midchest level. In one of the seven animals,
samples could not be obtained from the coronary venous
catheter. All hemodynamic measurements were repeated,
and rectal temperature was measured with animals standing
on the treadmill. Subsequently, a five-stage treadmill exer-
cise protocol was started [1, 2, 3, 4, and 5 km/h resulting in
85–90% of maximum heart rate (4a)]; each exercise stage
lasted 2–3 min. Hemodynamic variables were continuously
recorded, and blood samples were collected during the last
45 s of each exercise stage, at a time when hemodynamics had
reached a steady state. After completing the exercise protocol,
animals were allowed to rest on the treadmill for 90 min, and
then resting measurements were obtained and the five-stage
exercise protocol was repeated.
Adenosine receptor blockade. Ninety minutes after swine
had undergone a control exercise period, animals received an
infusion of 8-PT (5 mg/kg administered over 5 min into a
pulmonary artery catheter) to produce adenosine receptor
blockade (20). It has previously been shown that this dose of
8-PT produces .95% inhibition of adenosine-induced coro-
nary vasodilation in anesthetized swine (8) and awake dogs
(2, 10). Five minutes after completion of the 8-PT infusion,
resting measurements were obtained and the exercise proto-
col was repeated.
Contribution of changes in pH and PCO2 to the 8-PT-induced
alterations in ME˙O2. Because we observed that 8-PT de-
creased arterial and coronary venous PCO2 and increased
arterial pH, which could potentially increase coronary vasomo-
tor tone, we determined the effects of equivalent hyperventila-
tion-induced decreases in arterial and coronary venous PCO2
and increases in pH on ME˙O2 and PcvO2 in five swine (2
chronically instrumented ketamine-sedated swine and three
pentobarbital-anesthetized intubated open-chest animals)
(15). After 5 min of hyperventilation, arterial and coronary
venous samples were obtained. In addition, we obtained
arterial and coronary venous blood samples before and 5 min
after infusion of 1 M sodium hydrogen bicarbonate (Lansberg,
Uden, The Netherlands), which produced similar increases in
pH in the two chronically instrumented ketamine-sedated
swine.
Blood Gas Measurements
Blood samples were maintained in iced syringes until the
conclusion of each exercise trial. PO2 (mmHg), PCO2 (mmHg),
and pH were then immediately measured with a blood gas
analyzer (Acid-Base Laboratory model 505, Radiometer, Co-
penhagen, Denmark). O2 saturation (SO2) and Hb (g/100 ml)
were measured with a hemoximeter (model OSM2, Radiom-
eter, Copenhagen, Denmark).
Data Acquisition and Analysis
All hemodynamic data were recorded and digitized (400
Hz/channel) on-line using an eight-channel data-acquisition
program (ATCODAS, Dataq Instruments, Akron, OH) and
stored on a computer for later postacquisition off-line analysis
with a program written in MatLab (Mathworks, Natick, MA).
A minimum of 15 consecutive beats were selected for analysis
of the digitized hemodynamic signals. From these selected
beats the LV peak systolic pressure, mean aortic blood
pressure, mean pulmonary arterial and mean left atrial
pressure, mean ascending aortic blood flow, and mean coro-
nary Doppler shift were determined for each beat and aver-
aged.
Cardiac output was computed as the sum of ascending
aortic blood flow (measured with the electromagnetic flow probe)
and total coronary blood flow. Because the LAD coronary artery
supplies ,40% of the LV, total coronary blood flow was taken
as 2.5 times flow in the LAD coronary artery. Systemic and
coronary vascular resistance were calculated as the ratios of
mean aortic pressure to cardiac output and mean aortic
pressure to LAD coronary blood flow, respectively. Blood O2
content (µmol/ml) was computed as (0.621 ·Hba ·SO2) 1
(0.00131·PO2), where Hba is arterial Hb. MD˙O2 was computed
as the product of arterial O2 content and LAD coronary blood
flow; whole body O2 delivery was calculated as the product of
arterial O2 content and cardiac output. MV˙O2 in the region
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perfused by the LAD coronary artery was calculated as the
product of coronary blood flow and the difference in O2 content
between arterial and coronary venous blood; whole body O2
consumption (BV˙O2) was calculated as the product of cardiac
output and difference in O2 content between arterial and
mixed venous blood. ME˙O2 was computed as the ratio of
arterial-coronary venous O2 content difference to arterial O2
content; whole body O2 extraction (BE˙O2) was calculated as
the ratio of arterial-mixed venous O2 content difference to
arterial O2 content.
Statistical analysis of the exercise data was performed
using two-way (exercise and treatment) ANOVA for repeated
measures. When a significant effect of exercise was observed,
post hoc testing was done using Dunnett’s test. When a
significant effect of treatment was observed, post hoc testing
was done using paired t-test or Wilcoxon signed rank test
as appropriate. The effect of hyperventilation was tested
using paired t-test or Wilcoxon signed rank test. P # 0.05 was
considered statistically significant (2-tailed). Values are
means 6 SE.
Drugs
8-PT (Sigma-Aldrich, Bornem, Belgium) was dissolved in
20 ml of demineralized water at 30°C (pH 10–11). Fresh drug
solutions were prepared on each day.
RESULTS
Reproducibility of Responses to Exercise
Exercise increased cardiac output from 3.5 6 0.2
l/min at rest (supine) to 7.9 6 0.5 l/min at 5 km/h (P #
0.01), which was principally due to an increase in heart
rate from 110 6 4 to 242 6 4 beats/min (P # 0.01) as
stroke volume increased ,10% (Table 1). Because
afterload increased (reflected by the increase in LV
systolic pressure from 120 6 4 mmHg at rest to 145 6 5
mmHg at 5 km/h, P # 0.01), the increase in stroke
volume was likely the result of an increase in LV filling
pressure (reflected by the increase in left atrial pres-
sure from 6 6 1 to 14 6 2 mmHg, P # 0.01) and an
increase in LV contractility (reflected by the increase in
LV dP/dtmax from 3,080 6 290 to 6,220 6 380 mmHg/s,
P # 0.01). Mean aortic pressure decreased slightly
when the animals went from a supine to an upright
position, but during exercise, aortic pressure increased
from 92 6 4 mmHg while animals were standing to
97 6 4 mmHg at 5 km/h (P # 0.05). The 5% increase in
mean aortic blood pressure in the presence of a dou-
bling of cardiac output implies that systemic vascular
resistance had decreased. In contrast, mean pulmonary
arterial pressure increased from 14 6 1 to 33 6 2
mmHg (P # 0.01), and the driving pressure across the
pulmonary vascular bed increased virtually in parallel
with cardiac output, so that pulmonary vascular resis-
tance was not significantly altered. Blood flow through
the LAD coronary artery increased from 45 6 4 ml/min
at rest to 95 6 11 ml/min during the highest level of
exercise (P # 0.01; Table 1). After 90 min of rest, at a
time when all hemodynamic variables had returned to
baseline resting values, the second period of exercise
Table 1. Reproducibility of hemodynamic responses in swine during consecutive periods
of graded treadmill exercise
Rest Exercise, km/h
Supine Standing 1 2 3 4 5
Cardiac output, l/min
Control 3.560.2 4.560.3† 5.360.3† 6.160.4† 6.760.5† 7.460.5† 7.960.5†
Saline 3.760.3 4.860.3† 5.660.3† 6.060.3† 6.760.4† 7.260.4† 7.960.4†
Heart rate, beats/min
Control 11064 13466† 16166† 17963† 20566† 22965† 24264†
Saline 11365 13666† 15665† 16564†‡ 19366†‡ 21066†‡ 23466†‡
Mean aortic pressure, mmHg
Control 10262 9264† 8863† 9362† 9563† 9563† 9764†
Saline 10062 9063† 9163† 9162† 9062† 9463† 9463†
LV systolic pressure, mmHg
Control 12064 11864 12064 13064† 13164† 13964† 14565†
Saline 11963 12065 12566† 12565† 12764† 13665† 14165†
LV dP/dtmax, mmHg/s
Control 3,0806290 3,7906380† 4,1206400† 4,6406390† 5,0206300† 5,7906370† 6,2206380†
Saline 3,1406270 3,6806340† 4,1106360† 4,1006340†‡ 4,5806220†‡ 5,2006250†‡ 5,6706230†‡
Mean pulmonary arterial pressure,
mmHg
Control 1461 1261 1661 2161† 2762† 3062† 3362†
Saline 1661 1661 1961† 2061† 2462† 2962† 3361†
Mean left atrial pressure,* mmHg
Control 661 2261† 361 462 862 1162† 1462†
Saline 861 162† 362 462 663 962 1263
Pulmonary vascular resistance,*
mmHg·l21 ·min
Control 2.760.5 2.660.2 2.360.3 2.460.2 2.660.3 2.560.3 2.360.3
Saline 2.460.3 2.960.1 2.960.2 2.760.2 2.560.2 2.560.3 2.460.2
Coronary blood flow, ml/min
Control 4564 5266† 6367† 8168† 8469† 8868† 95611†
Saline 4565 5566† 6969† 7266† 8369† 91611† 97614†
Values are means 6 SE; n 5 7 unless otherwise noted. LV, left ventricle; dP/dtmax, maximum rate of rise in pressure. *n 5 4. †P # 0.05 vs.
supine; ‡P # 0.05 vs. corresponding control.
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Table 2. Reproducibility of blood gas and O2 transport responses in swine during consecutive periods
of graded treadmill exercise
Rest Exercise, km/h
Supine 1 2 3 4 5
Hb, g/100 ml
Control 8.060.2 8.260.4 8.560.3* 8.860.2* 8.860.3* 9.060.3*
Saline 7.760.3 8.060.3 8.060.3 8.360.3*† 8.360.3*† 8.560.2*†
PaCO2, mmHg
Control 4361 4261 4261 4161* 4061* 3961*
Saline 4361 4361 4261 4061* 4061* 3961
pHa
Control 7.4460.01 7.4660.01* 7.4660.01* 7.4660.01* 7.4660.01* 7.4760.01*
Saline 7.4560.01 7.4560.01 7.4660.01 7.4860.01* 7.4760.01 7.4860.01*
PaO2, mmHg
Control 10463 10463 10463 10764 10564 10664
Saline 10363 10062 10762 10764 10363 10464
SaO2, %
Control 9661 9761 9661 9661 9661 9661
Saline 9761 9661 9761 9761 9761 9761
CaO2, µmol/ml
Control 4.9260.14 5.0760.20 5.2060.19* 5.4060.13* 5.3960.15* 5.5160.17*
Saline 4.7460.17 4.9060.17 4.9660.21 5.1760.16*† 5.1460.16*† 5.2360.13*†
PvCO2, mmHg
Control 5261 5361 5362 5462* 5562* 5762*
Saline 5161 5361 5361 5361 5362 5561*
pH v
Control 7.3960.01 7.3960.01 7.3860.01 7.3860.01 7.3860.01 7.3660.01*
Saline 7.3960.01 7.3960.01 7.3960.01 7.3960.01 7.3960.01 7.3860.01
PvO2, mmHg
Control 4161 3461* 3361* 3162* 2962* 2561*
Saline 4261 3461* 3461* 3261* 2861* 2861*
SvO2, %
Control 5261 4061* 3861* 3462* 2962* 2361*
Saline 5461 4061* 3961* 3761* 3061* 2962*
CvO2, µmol/ml
Control 2.6260.09 2.0960.10* 2.0360.13* 1.9060.16* 1.6260.15* 1.3560.12*
Saline 2.6160.09 2.0360.04* 2.0060.07* 1.9660.12* 1.6160.10* 1.5460.12*
PcvCO2, mmHg
Control 5662 5662 5562 5561 5661 5761
Saline 5462 5562 5562 5561 5461 5562
pHcv
Control 7.3760.01 7.3860.01 7.3860.01 7.3860.01 7.3860.01 7.3860.01
Saline 7.3760.01 7.3860.01 7.3960.01 7.3960.01 7.3860.01 7.3860.01
PcvO2, mmHg
Control 24.160.7 24.360.9 24.660.5 24.060.7 23.760.7 23.461.1
Saline 24.460.8 24.560.9 24.660.9 24.460.8 24.960.7 23.760.8
ScvO2, %
Control 22.061.4 22.261.0 22.961.1 21.761.1 20.661.1 20.461.0
Saline 23.961.5 23.361.4 24.062.1 23.761.6 23.461.9 22.661.9
CcvO2, µmol/ml
Control 1.1060.06 1.1560.08 1.2060.07 1.2260.08 1.1560.08 1.1760.09
Saline 1.1360.06 1.1560.05 1.1960.11 1.2360.08 1.2460.10 1.2260.10
BV˙O2, mmol/min
Control 7.960.5 13.360.8* 16.760.9* 21.562.0* 25.262.0* 30.962.1*
Saline 7.760.4 13.761.0* 16.661.2* 19.161.1* 23.561.6* 26.561.4*†
BE˙O2, %
Control 4761 5961* 6161* 6563* 7062* 7661*
Saline 4561 5861* 6061* 6261* 6961* 7162*
MV˙O2, µmol/min
Control 172615 233628* 301635* 348643* 372637* 420661*
Saline 156617 239631* 256624* 313640* 353644* 394662*
ME˙O2, %
Control 7762 7761 7661 7761 7961 7961
Saline 7662 7661 7562 7662 7662 7762
Values are means 6 SE; n 5 7. PaCO2, pHa, PaO2, SaO2, and CaO2, arterial PCO2, pH, PO2, O2 saturation, and O2 content; PvCO2, pHv,
PvO2, SvO2, and CvO2, mixed venous PCO2, pH, PO2, O2 saturation, and O2 content; PcvCO2, pHcv, PcvO2, ScvO2, and CcvO2, coronary venous
PCO2, pH, PO2, O2 saturation, and O2 content; BV˙O2 and BE˙O2, whole body O2 consumption and extraction; MV˙O2 and ME˙O2, myocardial
O2 consumption and extraction. *P # 0.05 vs. supine; †P # 0.05 vs. corresponding control.
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resulted in almost identical hemodynamic responses to
exercise, with the exception of heart rate and LV
dP/dtmax, which were slightly (,10%) lower during
exercise at 2–5 km/h than during the first run (Table 1).
Exercise resulted in a decrease in arterial PCO2 from
43 6 1 mmHg at rest to 39 6 1 mmHg at 5 km/h and an
increase in arterial pH from 7.44 6 0.01 to 7.47 6 0.01
(both P # 0.05; Table 2). Arterial SO2 did not change,
but Hb and, hence, O2 content increased by 12% at the
highest level of exercise compared with resting condi-
tions. Mixed venous PO2, SO2, and O2 content decreased
during exercise, whereas mixed venous PCO2 increased
and pH decreased slightly. Because cardiac output and
the arteriovenous O2 content difference nearly doubled,
BV˙O2 increased fourfold from 7.9 6 0.5 to 30.9 6 2.1
mmol/min (P # 0.01; Table 2, Fig. 1). All variables
returned to baseline resting values within 90 min; a
second period of exercise resulted in nearly identical
responses, with the exception of a slightly lower Hb and
arterial O2 content at 3–5 km/h and a slightly lower
BV˙O2 at 5 km/h (Table 2, Fig. 1).
Exercise had no effect on coronary venous PCO2, pH,
PO2, SO2, or O2 content (Table 2, Fig. 2). MV˙O2 increased
from 172 6 15 to 420 6 61 µmol/min, whereas MD˙O2
increased from 214 6 25 to 535 6 81 µmol/min (both
P # 0.01). Consequently, ME˙O2 (i.e., the ratio of MV˙O2 to
MD˙O2) was not altered during exercise. All variables
returned to baseline resting values within 90 min.
Despite the slightly lower heart rate, LV dP/dtmax, and
arterial O2 content during the second control run, there
were no differences between the two control runs with
respect to coronary vascular resistance, ME˙O2, MD˙O2,
and PcvO2 when plotted as a function of MV˙O2 (Fig. 2).
Adenosine Receptor Blockade
Except for a 10% increase in heart rate, 8-PT had no
effects on systemic and pulmonary hemodynamics at
rest (Table 3). During exercise, heart rate at 5 km/h and
coronary blood flow at 1 km/h were slightly higher than
during control conditions.
8-PT decreased PCO2 and increased pH in arterial,
mixed venous, and coronary venous blood (Table 4).
Arterial PO2, SO2, and O2 content were maintained, but
mixed venous PO2, SO2, and O2 content were lower in
the presence of adenosine receptor blockade, reflecting
an increase in BE˙O2 (Table 4, Fig. 1). The latter could
only in part be explained by the increments in BV˙O2,
inasmuch as the relation between BV˙O2 and BE˙O2
shifted upward toward higher BE˙O2 (not shown). The
relation between BV˙O2 and systemic vascular resis-
tance was also shifted upward toward higher resistance
values (Fig. 1), suggesting that adenosine receptor
blockade produced systemic vasoconstriction, which
limited systemic O2 delivery, thereby resulting in an
increase in BE˙O2 and, hence, a decrease in mixed
venous PO2.
Administration of 8-PT resulted in increases in MV˙O2
that reached levels of statistical significance during
exercise at 1 and 3 km/h. Thus the increase in coronary
blood flow and MD˙O2 at 1 km/h was likely due to an
increase in O2 requirements. Importantly, after admin-
Fig. 1. Effects of saline (A and B) and adenosine
receptor blockade produced by 8-phenyltheophylline
(8-PT, 5 mg/kg iv; C and D) on relations between
whole body O2 consumption (body V˙O2) and systemic
vascular resistance (SVR) and between whole body
V˙O2 and mixed venous PO2. Values (means 6 SE)
were obtained at rest (supine) and during 5 levels of
treadmill exercise. *P # 0.05 vs. control.
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Fig. 2. Effects of saline (A–D) and adenosine receptor blockade produced by 8-PT (5 mg/kg iv; E–H) on relations
between myocardial O2 consumption (MV˙O2) and coronary vascular resistance (CVR), myocardial O2 delivery
(MD˙O2), myocardial O2 extraction (ME˙O2), and coronary venous PO2 (PcvO2). Values (means 6 SE) were obtained at
rest (supine) and during 5 levels of treadmill exercise. *P # 0.05 vs. control.
Table 3. Hemodynamic effects of adenosine receptor blockade in swine during graded treadmill exercise
Rest Exercise, km/h
Supine Standing 1 2 3 4 5
Cardiac output, l/min
Control 3.560.1 4.360.2† 5.460.3† 6.260.3† 6.660.4† 7.160.4† 7.660.3†
8-PT 3.960.3 4.560.2† 5.660.2† 6.160.2† 6.560.2† 7.260.3† 7.860.3†
Heart rate, beats/min
Control 11165 12967† 16366† 18168† 200611† 22869† 24366†
8-PT 12368‡ 13266† 16763† 19167† 21269† 23469† 25367†‡
Mean aortic pressure, mmHg
Control 9864 9364 9464 9565 9665 9665 9565
8-PT 10868 103610 10468 10167 10268 10067 10067
LV systolic pressure, mmHg
Control 11565 11164 11966 12366† 12765† 13064† 13665†
8-PT 12569 124610 132610 13168 13469† 13966† 14464†
LV dP/dtmax, mmHg/s
Control 2,9106400 3,1206350 4,1106520† 4,6106440† 5,1806340† 5,7006270† 6,2906350†
8-PT 3,1006450 3,3006410 4,4106510† 4,9606450† 5,4406530† 6,0806330† 6,6006280†
Mean pulmonary arterial pressure,
mmHg
Control 1661 1761 2062 2361† 2862† 3362† 3562†
8-PT 1661 1461 1861 2161† 2462† 2962† 3362†
Mean left atrial pressure,* mmHg
Control 763 262 162 362 663 1063 1162†
8-PT 461 262 161 362 662 862 1362†
Pulmonary vascular resistance,*
mmHg·l21 ·min
Control 2.860.7 3.560.5 3.360.4 3.160.4 3.160.4 3.060.4 2.960.4
8-PT 3.260.3 2.960.2 2.860.2 2.760.2 2.660.2 2.560.2 2.560.2
Coronary blood flow, ml/min
Control 4563 5264† 6662† 7564† 7765† 8164† 9064†
8-PT 5166 5665† 7464†‡ 8065† 8265† 8568† 9167†
Values are means 6 SE; n 5 7 unless otherwise noted. 8-PT, 8-phenyltheophylline (5 mg/kg iv). *n 5 4. †P # 0.05 vs. supine; ‡P # 0.05 vs.
corresponding control.
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istration of 8-PT, MD˙O2 was slightly lower at each level
of MV˙O2 than under control conditions (P # 0.05) so
that ME˙O2 increased and PcvO2 decreased (Table 4,
Fig. 2), indicating an increase in vasomotor tone in the
coronary resistance vessels that restricted MD˙O2. In
support of this finding, the relation between MV˙O2 and
coronary vascular resistance was shifted toward higher
vascular resistance values (Fig. 2).
Table 4. Effects of adenosine receptor blockade on O2 balance in swine during graded treadmill exercise
Rest Exercise, km/h
Supine 1 2 3 4 5
Hb, g/100 ml
Control 7.860.4 8.460.3* 8.760.3* 8.860.2* 9.060.2* 9.360.3*
8-PT 8.060.3 8.360.4 8.560.4* 8.660.5* 9.060.3* 9.160.4*
PaCO2, mmHg
Control 4661 4662 4362 4462 4262 4261*
8-PT 3662† 3661† 3861† 3661† 3761† 3561†
pHa
Control 7.4560.01 7.4660.01 7.4760.01 7.4760.01 7.4860.01 7.4760.01
8-PT 7.5360.01† 7.5260.01† 7.5060.01† 7.5260.01† 7.5160.01† 7.5260.01†
PaO2, mmHg
Control 10363 9864 10165 9665 10163 9962
8-PT 11463 11265 10265 10664 10165 10564
SaO2, %
Control 9661 9561 9661 9561 9661 9561
8-PT 9861 9761 9661 9761 9661 9761
CaO2, µmol/ml
Control 4.7760.26 5.1360.22* 5.2760.21* 5.2860.15* 5.5060.17* 5.6060.20*
8-PT 4.9960.22 5.1360.23 5.2360.21 5.3360.28 5.4860.19* 5.6360.23*
PvCO2, mmHg
Control 5262 5462 5561* 5462* 5562* 5662*
8-PT 4661† 4861† 5061*† 4962*† 5062*† 5162*†
pHv
Control 7.4060.01 7.3960.01 7.3960.01 7.3960.01 7.3960.01 7.3760.01
8-PT 7.4560.01† 7.4460.01† 7.4360.01*† 7.4360.01*† 7.4260.01*† 7.4160.01*†
PvO2, mmHg
Control 4261 3561* 3361* 3261* 3161* 2861*
8-PT 3661† 3161*† 3061*† 2961* 2761*† 2561*†
SvO2, %
Control 5661 4162* 3962* 3662* 3362* 2862*
8-PT 4862† 3762*† 3562*† 3363* 3062*† 2562*†
CvO2, µmol/ml
Control 2.7660.18 2.2260.16* 2.1460.15* 2.0160.12* 1.9160.13* 1.6760.15*
8-PT 2.4460.14† 1.9660.15*† 1.8960.16* 1.8160.22* 1.7060.17* 1.4360.14*†
PcvCO2, mmHg
Control 5662 5662 5762 5762 5462 5662
8-PT 4961† 5061† 5161† 5062† 5162 5061†
pHcv
Control 7.4060.01 7.4160.01 7.3960.01 7.4060.01 7.4060.01 7.4060.01
8-PT 7.4560.01† 7.4460.02† 7.4460.01† 7.4460.01† 7.4360.01 7.4260.01†
PcvO2, mmHg
Control 24.561.0 23.860.9 23.360.4 24.560.8 23.360.4 22.860.3
8-PT 19.260.8† 19.460.8† 19.860.9† 19.260.6† 19.160.8† 18.960.8†
ScvO2, %
Control 23.461.4 22.560.9 21.860.8 22.560.5 21.861.2 21.061.1
8-PT 18.861.1† 18.460.9† 17.960.9† 17.461.1† 16.961.5† 16.361.3†
CcvO2, µmol/ml
Control 1.1860.10 1.2360.04 1.1960.05 1.2760.03 1.2660.06 1.2460.06
8-PT 0.9660.06 0.9960.04† 0.9960.03† 0.9860.05† 0.9660.07† 0.9460.05†
BV˙O2, mmol/min
Control 7.160.3 15.961.5* 19.561.5* 21.461.7* 25.862.1* 30.161.9*
8-PT 10.161.3† 17.861.2*† 20.661.4* 23.161.9* 27.461.9* 32.862.5*†
BE˙O2, %
Control 4261 5762* 6062* 6262* 6562* 7062*
8-PT 5162† 6262*† 6462*† 6663* 6963*† 7562*†
MV˙O2, µmol/min
Control 167618 267620* 307626* 317620* 350622* 399627*
8-PT 213632 314618*† 346622* 369623*† 391627* 422624*
ME˙O2, %
Control 7661 7661 7761 7661 7761 7861
8-PT 8161† 8161† 8161† 8261† 8262† 8361†
Values are means 6 SE; n 5 7. *P # 0.05 vs. supine; †P , 0.05 vs. corresponding control.
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Contribution of Changes in pH and PCO2
to 8-PT-Induced Alterations in ME˙O2
Mechanical hyperventilation decreased arterial PCO2
from 47 6 5 to 38 6 5 mmHg and increased pH from
7.44 6 0.03 to 7.51 6 0.04 (all P # 0.05); similar
changes were observed in the coronary venous blood.
However, no changes were observed in PcvO2 or ME˙O2
(Table 5). Similarly, an increase in arterial pH from
7.39 6 0.03 to 7.50 6 0.04 produced by infusion of 1 M
HCO3
2 in two sedated swine had no effect on PcvO2
(23.6 6 0.6 and 23.3 6 1.8 mmHg before and after
HCO3
2 administration, respectively) or on ME˙O2 (77 6 3
and 77 6 4%, respectively). These findings indicate that
8-PT-induced changes in PCO2 and pH were not respon-
sible for its vasoconstrictor actions.
DISCUSSION
The present study describes the contribution of aden-
osine in maintaining the balance between MV˙O2 and
MD˙O2 in awake swine at rest and during treadmill
exercise. The major findings of the present study
were as follows:1) ME˙O2 and PcvO2 were not altered
from resting levels during treadmill exercise at up to
80–90% of maximum heart rate (4a), indicating that
the exercise-induced increases in MV˙O2 were matched
by equivalent increases in MD˙O2. 2) Adenosine receptor
blockade increased ME˙O2 and decreased PcvO2 under
resting conditions as well as during exercise, indicating
that endogenously released adenosine exerted a vasodi-
lator influence that contributed to maintaining MD˙O2
commensurate with O2 demands. 3) Adenosine was not
mandatory for the exercise-induced coronary vasodila-
tion. 4) Changes in arterial or coronary venous PCO2 or
pH could not account for these findings.
Adenosine has been proposed as one of the messen-
gers that couples myocardial O2 demand to vasomotor
tone of the coronary resistance vessels (4, 30). Adenine
nucleotides do not cross the cell membrane of cardiac
myocytes, but adenosine formed from the action of
nucleotide phosphorylase on AMP can be transported
out of myocytes into the interstitial space (36). On
entering the interstitial space, adenosine can interact
with A2 receptors on coronary vascular smooth muscle
to produce vasodilation and an increase in coronary
blood flow (30). Previous studies in dogs have demon-
strated that endogenous adenosine production is not
mandatory for maintaining resting coronary blood flow.
Thus studies in anesthetized open-chest dogs have
generally failed to demonstrate an effect of intracoro-
nary adenosine deaminase (22, 24, 33) or intravenous
aminophylline to block adenosine receptors (19, 34) on
basal coronary blood flow, although some studies have
reported an increase in coronary vascular resistance
after administration of the selective adenosine receptor
antagonist sulfophenyltheophylline (27). Similarly, in
doses that caused marked inhibition of exogenous
adenosine-induced coronary vasodilation, intracoro-
nary adenosine deaminase or intravenous 8-PT had no
effect on resting coronary blood flow, ME˙O2, or PcvO2 in
awake dogs (2).
In the in vivo canine heart, adenosine release is
enhanced during conditions of increased myocardial O2
demand (1, 14, 28, 39). However, demonstration of an
essential role for adenosine in mediating exercise-
induced coronary vasodilation requires that interrup-
tion of the adenosine effect interferes with exercise-
induced coronary vasodilation. Bache et al. (2) examined
the effects of adenosine receptor blockade with 8-PT as
well as augmented adenosine catabolism produced by
intracoronary adenosine deaminase in exercising dogs.
Adenosine antagonism inhibited coronary vasodilation
evoked by ischemia; adenosine deaminase caused a
33–39% decrease in reactive hyperemia after 5- to 20-s
coronary occlusions, whereas 8-PT caused a 40–62%
decrease in reactive hyperemia. Neither agent signifi-
cantly changed heart rate or arterial pressure during
treadmill exercise. Furthermore, neither the absolute
values for MV˙O2, coronary blood flow, and PcvO2 nor the
relationship between these variables was altered by
adenosine receptor blockade or adenosine deaminase
(2). These findings indicate that adenosine is not obliga-
tory for the increase in coronary blood flow produced by
exercise in the dog heart.
In contrast to the results obtained in the dog heart,
there is ample evidence that adenosine contributes to
regulation of coronary vasomotor tone in the human
heart. Edlund et al. (11–13) examined the effect of
adenosine receptor blockade with theophylline on coro-
nary sinus blood flow measured at rest and during
supine bicycle exercise in normal young adult human
subjects. Theophylline (3–6 mg/kg iv) caused a small
increase in heart rate (13) and the rate-pressure prod-
uct (12), but, despite increased myocardial O2 demands,
coronary blood flow and coronary venous SO2 were
lower, whereas coronary vascular resistance and ME˙O2
were higher, after theophylline at rest and during
exercise (11–13). The results of the present study
obtained in awake swine support the findings by Ed-
lund and co-workers and suggest that endogenous
adenosine exerts a vasodilator influence on the coro-
nary circulation at rest and during exercise but is not
mandatory for the increase in coronary blood flow and
decrease in coronary vascular resistance produced by
exercise in swine and humans. These findings could be
interpreted to suggest that adenosine contributes to a
basal offset point of coronary vasomotor tone but that
adenosine does not contribute to the decrease in vasomo-
tor tone produced by exercise. However, in closed-chest
Table 5. Effects of hyperventilation on blood gases
and ME˙O2
Baseline Hyperventilation
PaCO2, mmHg 4765 3865*
pHa 7.4460.03 7.5160.04*
PaO2, mmHg 9565 10964*
PcvCO2, mmHg 5665 4766*
pHcv 7.3860.03 7.4460.04*
PcvO2, mmHg 22.360.7 22.461.7
ME˙O2, % 7762 7562
Values are means 6 SE; n 5 5. *P # 0.05 vs. baseline.
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sedated swine, increased adenosine catabolism with
intracoronary administration of adenosine deaminase,
which had no effect on the steady-state coronary blood
flow response to isoproterenol (after 10 min of infusion),
markedly blunted the early (at 1 min) coronary blood
flow response to intracoronary infusions of isoproter-
enol (18). In the present study we obtained measure-
ments after 2–3 min of exercise, so we cannot exclude
the possibility that adenosine may have contributed to
the early adaptation of vasomotor tone (#1 min) during
treadmill exercise. In addition, it is possible that aden-
osine also contributes to coronary vasodilation during
steady-state exercise but that other vasodilator mecha-
nisms, e.g., NO or ATP-sensitive K1 channel activation,
act to compensate and mediate the vasodilation when
adenosine receptors are blocked (26). Future studies,
employing a combination of blockers of these different
vasodilator systems, are needed to determine whether
adenosine contributes to the coronary vasodilation
produced by exercise in swine. However, the present
study clearly demonstrates that adenosine is not man-
datory for steady-state exercise-induced vasodilation in
swine.
In dogs the exercise-induced increase in coronary
blood flow does not fully match the increase in myocar-
dial O2 demand, so even during mild-to-moderate exer-
cise (,70% of maximum heart rate) ME˙O2 increases
and, hence, PcvO2 decreases (2, 14, 28). In contrast, in
humans, minimal changes in ME˙O2 occur at mild-to-
moderate levels of exercise, although an increase in
ME˙O2 and a decrease in coronary venous O2 content
have been reported in humans during heavy exercise
(.85% of maximum heart rate) (26). Similar to hu-
mans, ME˙O2 and PcvO2 did not change significantly
in swine during treadmill exercise in the present study.
Interestingly, Hall et al. (21) reported that interstitial
levels of adenosine increased during b-adrenergic stimu-
lation with dobutamine in anesthetized swine in the
presence of maintained PcvO2 and interstitial lactate
levels, suggesting that adenosine could have contrib-
uted to the maintained PcvO2 during exercise in the
present study. However, the results of the present study
do not support such a role for adenosine, inasmuch as
8-PT resulted in similar decreases in PcvO2 at rest and
during exercise.
In the present study, adenosine receptor blockade
increased coronary as well as systemic vascular resis-
tance at rest and during exercise. Because we did not
measure regional blood flows, we cannot determine
which vascular beds responded with an increased vas-
cular resistance. However, during exercise a major part
of cardiac output is directed toward the active skeletal
muscle groups (26). Adenosine has been invoked in the
regulation of skeletal muscle vascular tone during
exercise. Thus the exercise-induced skeletal muscle
hyperemia was blunted by increased adenosine catabo-
lism with adenosine deaminase (35), whereas a de-
crease in adenosine uptake produced by dipyridamole
increased skeletal muscle blood flow during exercise
(25). The results from the present study are consistent
with a vasodilator influence exerted by adenosine on
skeletal muscle resistance vessels during treadmill
exercise.
Adenosine receptor blockade had no effect on pulmo-
nary vascular resistance, which would appear to indi-
cate that endogenous adenosine did not contribute to
regulation of pulmonary vascular resistance at rest or
during exercise. However, A1 and A2 receptors, both of
which are present in the pulmonary bed, mediate
pulmonary smooth muscle contraction and relaxation,
respectively (3). Because 8-PT is a nonselective A1/A2-
receptor antagonist, we cannot exclude the possibility
that endogenous adenosine may contribute to regula-
tion of pulmonary resistance vessel tone but that lack of
effect of 8-PT on the pulmonary bed could be due to its
opposing vasomotor actions via simultaneous A1 and A2
blockade. Future studies using selective A1- and A2-
receptor antagonists are required to determine the role
of A1- and A2-receptor subtypes.
In conclusion, ME˙O2 and PcvO2 were not altered from
resting levels in swine exercising on a treadmill at
levels up to 80–90% of maximum heart rate, indicating
that the exercise-induced increases in MV˙O2 were
matched by equivalent increases in MD˙O2. Adenosine
receptor blockade resulted in an increased ME˙O2 and a
decreased PcvO2 under resting conditions and during
exercise, indicating that endogenously released adeno-
sine exerted a vasodilator influence that contributed to
maintaining MD˙O2 commensurate with O2 demands.
However, adenosine was not mandatory for the exercise-
induced coronary vasodilation in swine.
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